Vir Biotechnology, Inc. financial data

Symbol
VIR on Nasdaq
Location
San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 745% % -29%
Debt-to-equity 25% % 35%
Return On Equity -51% % -38%
Return On Assets -41% % -31%
Operating Margin -3254% % -320%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 139,125,032 shares 1%
Common Stock, Shares, Outstanding 139,022,594 shares 1.7%
Entity Public Float $745,600,000 USD -59%
Common Stock, Value, Issued $14,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 138,930,173 shares 1.7%
Weighted Average Number of Shares Outstanding, Diluted 138,930,173 shares 1.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $16,860,000 USD -79%
Revenue from Contract with Customer, Excluding Assessed Tax $16,860,000 USD -90%
Cost of Revenue $745,000 USD -21%
Research and Development Expense $473,700,000 USD -7%
Costs and Expenses $565,417,000 USD -18%
Operating Income (Loss) $548,557,000 USD 9.9%
Nonoperating Income (Expense) $49,172,000 USD -30%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $499,385,000 USD 7.4%
Income Tax Expense (Benefit) $268,000 USD -5.1%
Net Income (Loss) Attributable to Parent $499,653,000 USD 6.3%
Earnings Per Share, Basic -3 USD/shares 7.7%
Earnings Per Share, Diluted -3 USD/shares 7.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $170,084,000 USD 1%
Marketable Securities, Current $327,750,000 USD -56%
Cash, Cash Equivalents, and Short-term Investments $1,190,000,000 USD -30%
Other Assets, Current $100,000 USD -99%
Assets, Current $545,684,000 USD -48%
Property, Plant and Equipment, Net $58,203,000 USD -10%
Operating Lease, Right-of-Use Asset $63,555,000 USD 4.6%
Intangible Assets, Net (Excluding Goodwill) $7,924,000 USD -59%
Goodwill $16,937,000 USD -0.01%
Assets $1,019,453,000 USD -32%
Accounts Payable, Current $6,847,000 USD -6.3%
Liabilities, Current $75,222,000 USD -36%
Contract with Customer, Liability, Noncurrent $9,433,000 USD
Operating Lease, Liability, Noncurrent $91,215,000 USD -2.3%
Other Liabilities, Noncurrent $13,305,000 USD -4.2%
Liabilities $223,355,000 USD -13%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,911,000 USD -270%
Retained Earnings (Accumulated Deficit) $1,154,848,000 USD -76%
Stockholders' Equity Attributable to Parent $796,098,000 USD -36%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $796,098,000 USD -36%
Liabilities and Equity $1,019,453,000 USD -32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $78,116,000 USD 29%
Net Cash Provided by (Used in) Financing Activities $598,000 USD 293%
Net Cash Provided by (Used in) Investing Activities $126,818,000 USD 346%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 139,022,594 shares 1.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $49,300,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $179,256,000 USD -32%
Deferred Tax Assets, Valuation Allowance $453,394,000 USD 27%
Operating Lease, Liability $97,891,000 USD -21%
Depreciation $11,300,000 USD -28%
Payments to Acquire Property, Plant, and Equipment $1,629,000 USD -13%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $502,691,000 USD 5.2%
Lessee, Operating Lease, Liability, to be Paid $123,509,000 USD -21%
Property, Plant and Equipment, Gross $102,691,000 USD 2.7%
Operating Lease, Liability, Current $8,960,000 USD -54%
Lessee, Operating Lease, Liability, to be Paid, Year Two $12,625,000 USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year One $12,637,000 USD -33%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $25,618,000 USD -20%
Lessee, Operating Lease, Liability, to be Paid, Year Three $12,912,000 USD -24%
Deferred Tax Assets, Operating Loss Carryforwards $180,130,000 USD 30%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $17,500,000 USD 18%
Lessee, Operating Lease, Liability, to be Paid, Year Four $13,265,000 USD -22%
Additional Paid in Capital $1,952,843,000 USD 3.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $2,867,000 USD -37%
Deferred Tax Assets, Net of Valuation Allowance $25,534,000 USD -38%
Share-based Payment Arrangement, Expense $53,707,000 USD -41%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%